HB 239 – Illinois

Status: Inactive / Dead
Year Introduced: 2017
Link: http://www.ilga.gov/legislation/billstatus.asp?DocNum=0239&GAID=14&GA=100&DocTypeID=HB&LegID=99222&SessionID=91

DRUG MANUFACTURER DISCLOSURES: Requires manufacturers of brand name or generic prescription drugs to notify State purchasers, health insurers, health care service plan providers, pharmacy benefit managers, and the General Assembly of specified increases in drug prices at least 60 days before such increase and the cost of specified new prescription drugs within 3 days after approval by the U.S. Food and Drug Administration.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found

Leave A Comment